Full-Time

Accounts Payable Manager

Sotera Health

Sotera Health

1,001-5,000 employees

Outsourced sterilization and lab testing provider.

No salary listed

Seven Hills, OH, USA

Hybrid

Hybrid work arrangement; some on-site days in Broadview Heights, OH.

Category
Accounting (2)
,
Required Skills
Excel/Numbers/Sheets
Requirements
  • Bachelor’s degree in Finance or Accounting preferred, experience in lieu of degree will be considered
  • Minimum 7 years progressive full cycle accounts payable experience, preferably in a shared services environment, including 2-4+ years in people leadership roles
  • Strong Excel spreadsheet skills (pivot tables, v-lookups, etc.) and solid knowledge of other Microsoft Office products
  • Strong written and verbal communication skills
  • Experience with JD Edwards Enterprise One (JDE E1) preferred
  • Ability to multi-task and adhere to tight deadlines
Responsibilities
  • Manage day-to-day Accounts Payable processes, ensuring timely processing of all invoices and vendor payments with the highest quality of service
  • Lead the Accounts Payable team - setting clear goals, service level agreements (SLAs), schedules, and development plans; foster a culture of accountability and continuous improvement
  • Develop, maintain, and improve key performance indicators that measure and track performance and efficiency of team and related processes (e.g. touchless invoice rate, invoice cycle time, etc.)
  • Review weekly payment runs for accuracy
  • Create, implement, maintain and adhere to standard Accounts Payable policies, processes, procedures, and internal controls ensuring proper communication, training and compliance
  • Oversee and maintain approval workflows according to the Company’s approval policy
  • Resolve complex invoice discrepancies timely and provide requested information to internal customers and vendors as needed, escalate issues effectively
  • Identify and implement continuous process improvement opportunities, including the utilization of technology solutions that drive efficiency
  • Enhance supplier relationships through predictable turnaround times, transparent communication, and efficient dispute resolution
  • Periodic review and clean-up of Accounts Payable aging reports to resolve outstanding balances
  • Work collaboratively across Accounting, Procurement, Treasury and other business partners to answer questions and support the business
  • Support month-end Accounts Payable close processes, ensuring tasks are completed timely in accordance with Corporate accounting time frames
  • Manage, maintain and enhance processes around tax reporting (e.g. 1099s, FATCA, GST, etc.)
  • Work with internal and external auditors to support our internal control assertions and financial statement audit
  • Special projects as assigned to include integration of acquisitions, etc.
Desired Qualifications
  • Multi-national experience with multi-entity and multi-currency operations is highly desirable
  • Leadership – outstanding people leader, organizational skills and ability to effectively lead a team within a high volume, service-related atmosphere, someone who encourages his or her team to contribute thoughts and ideas to drive improvement
  • Analytical Rigor – a detail-oriented professional who can uses data to diagnose issues, prioritize fixes, and report outcomes
  • Continuous improvement– an energetic individual who is not satisfied with the status quo and is always focused on improvement. Designs and enforces scalable SOPs; anticipates bottlenecks and eliminates waste
  • Change management– Plans, prepares communications, trains and sustains new ways of working
  • Interpersonal skills – a relationship builder with excellent communication skills (verbal and written) and proven ability to effectively communicate at all levels
  • Cross-functional influence – Builds trust across Accounting, Procurement, Treasury and other key stakeholders
  • Proactive– a self-starter who addresses each task with a sense of urgency and can generate a high volume of quality work products
  • Problem-solver – Ability to reach solid solutions utilizing logical thinking, prioritization and decision-making skills

Sotera Health provides sterilization and lab testing services to ensure the safety of medical devices, pharmaceuticals, and food products. The company operates through three divisions: Sterigenics, which uses methods like Gamma and X-ray to eliminate contaminants; Nordion, which supplies the Cobalt-60 isotopes needed for irradiation; and Nelson Labs, which performs over 800 microbiological and analytical tests. Unlike many competitors, it offers a fully integrated supply chain by producing its own sterilization sources while maintaining a global network of 63 facilities and labs. Its goal is to protect global health by providing the mission-critical services required to bring safe healthcare products to market.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Broadview Heights, Ohio

Founded

2017

Simplify Jobs

Simplify's Take

What believers are saying

  • Sterigenics volumes grew 8% in 2025, driving mid-to-high single-digit growth.
  • Q1 2026 operating margin hit 28.2%, up from 22.4%, via pricing power.
  • Sessa Capital bought $175.8M stake in February 2026, signaling investor confidence.

What critics are saying

  • EPA EtO enforcement and California bans constrain Sterigenics capacity by 2027.
  • Q1 2026 free cash flow plunged to negative $16.73M from $35.6M prior year.
  • Nelson Labs underperforms with low-single-digit growth versus Sterigenics' 8% volumes.

What makes Sotera Health unique

  • Sotera Health integrates Sterigenics, Nordion, and Nelson Labs for end-to-end sterilization and testing.
  • Nordion supplies Cobalt-60 with 70-year reliability for gamma irradiation worldwide.
  • Nelson Labs performs over 900 microbiological and analytical tests across 15 global labs.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Sotera Health who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Sick Leave

Paid Holidays

401(k) Retirement Plan

401(k) Company Match

Paid Parental Leave

Education Assistance

Employee Assistance Program (EAP)

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
The Globe and Mail
Mar 24th, 2026
A $175 Million Move Into Sotera Health Signals Potential Opportunity Amid 21% Stock Drop

Detailed price information for Capital One Financial Corp (COF-N) from The Globe and Mail including charting and trades.

Intellectia.AI
Mar 23rd, 2026
Sessa Capital buys $175.8M stake in Sotera Health as shares outperform S&P 500

Sessa Capital has acquired an additional 10,630,381 shares of Sotera Health for approximately $175.80 million on 17 February 2026, bringing its quarter-end position value to $206.47 million. The transaction signals strong confidence in the healthcare services company. Sotera Health shares traded at $13.99 on Monday, representing an 18% gain over the past year, slightly outperforming the S&P 500's 15% increase. The company has generated revenue of approximately $1.16 billion and adjusted EBITDA near $600 million. Despite facing litigation and regulatory risks, Sotera Health's sustained growth potential continues attracting long-term investor interest. The substantial investment by Sessa Capital reinforces the company's position within the asset manager's portfolio.

Yahoo Finance
Mar 23rd, 2026
Sessa Capital invests $175M in Sotera Health following 21% stock drop

Sessa Capital purchased 10.63 million shares of Sotera Health in the fourth quarter for an estimated $175.80 million, according to a Securities and Exchange Commission filing dated 17 February. The stake now represents nearly 7% of Sessa Capital's reportable assets under management. Sotera Health provides sterilisation services and laboratory testing for medical device and pharmaceutical industries. The company generated $1.2 billion in revenue and $77.9 million in net income over the trailing twelve months. Despite 20 years of steady growth and adjusted EBITDA approaching $600 million, the stock has declined as investors focus on litigation risks, high leverage and regulatory concerns. The shares currently trade at $13.99, up 18% over the past year, with a market capitalisation of $4.0 billion.

Yahoo Finance
Mar 22nd, 2026
Sotera Health CFO reaffirms 5%–6.5% organic growth for 2026, eyes $500M–$600M free cash flow

Sotera Health's CFO Jon Lyons reaffirmed constant-currency organic growth guidance of 5% to 6.5% for 2026 at the KeyBanc Healthcare Forum. Sterigenics is expected to deliver mid- to high-single-digit growth, whilst Nordion and Nelson Labs will see lower-single-digit growth. The company closed 2025 with 5.2% organic revenue growth, maintaining over 50% EBITDA margins with a 118-basis-point improvement. Weaker Nelson Labs results were offset by stronger Sterigenics volumes of approximately 8%. Management prioritises free cash flow and capital discipline, targeting $500 million to $600 million over three years. Capital expenditure is expected to drop significantly in 2027 as projects complete. Net leverage has improved towards the 2x–3x target, providing flexibility for debt reduction, acquisitions or share buybacks.

Yahoo Finance
Mar 2nd, 2026
Sotera Health up 30% in a year as fund trims $3.6M stake but maintains conviction

Ananym Capital Management sold 217,684 shares of Sotera Health for an estimated $3.60 million in February 2026, according to an SEC filing. Despite the sale, Sotera Health remains a significant holding at 8.65% of Ananym's assets under management. Sotera Health shares were trading at $17.09 as of 17 February 2026, up nearly 30% over the past year and outperforming the S&P 500 by 14.86 percentage points. The company provides sterilisation services and laboratory testing for medical device, pharmaceutical and food industries. Sotera recently reported its 20th consecutive year of revenue growth, with 2025 revenues rising nearly 6% to $1.16 billion. Management has guided for another 5% to 6.5% revenue increase in 2026, with adjusted EBITDA growth of 5.5% to 7%.